´ëÇѳ»ºÐºñÇÐȸ SICEM 2022(The 10th Seoul International Congress of Endocrinology and Metabolism) (2ÀÏÂ÷) : 2022-10-29±³À°ÀÏÀÚ : 2022-10-29
±³À°Àå¼Ò : ±è´ëÁßÄÁº¥¼Ç¼¾ÅÍ
±³À°ÁÖÁ¦ :
(¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà) SICEM 2022(The 10th Seoul International Congress of Endocrinology and Metabolism) (2ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѳ»ºÐºñÇÐȸ
´ã´çÀÚ : ¹Ú¼¼Çö
¿¬¶ôó : 02-2038-0072
À̸ÞÀÏ :
endo@endocrinology.or.kr ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 1000¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
±¤ÁÖ±¤¿ª½Ã±³À°½Ã°£ : 16 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 150,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 10-29 Room 4 07:30~07:50 New Paradigm of Glycemic Variability: EVERGREEN Study ¾ç¿©¸®(The Catholic University of Korea)
±³À°½Ã°£ 10-29 Room 5 07:30~07:50 Optimal LDL-C Targets in Patients with Diabetes Mellitus: The Lower, the Better? ¼´ÙÇý(Inha University, Korea)
±³À°½Ã°£ 10-29 Room 5 07:50~08:10 Strategy of Blood Pressure Intervention in the Elderly and DM Patients È«»ó¸ð(Hanyang University)
ÈÞ½Ä 10-29 08:10~08:30 ÈÞ½Ä ()
±³À°½Ã°£ 10-29 Room 1 08:30~09:20 Genetic Causes of Primary Aldosteronism: Impact of Age, Sex, and Race William RAINEY(University of Michigan)
±³À°½Ã°£ 10-29 Room 2 08:30~09:20 Short or Long-term Osteoporosis Therapy by Risk Stratification Serge FERRARI(University of Geneva)
ÈÞ½Ä 10-29 09:20~09:30 ÈÞ½Ä ()
±³À°½Ã°£ 10-29 Room 1 09:30~10:10 Thyroid-associated Orbitopathy: From Bench to Bedside George J. KAHALY(Johannes Gutenberg University (JGU) Medical Center)
ÈÞ½Ä 10-29 10:10~10:20 ÈÞ½Ä ()
±³À°½Ã°£ 10-29 Room 1 10:20~10:40 Managing Puzzling Osteoporosis Patients Suzanne Jan DE BEUR(Johns Hopkins University)
±³À°½Ã°£ 10-29 Room 1 10:40~11:00 How to Prevent Osteonecrosis of the Jaw in Patients Taking Anti-resorptive Drugs ¹Ú¿ø¼(Yonsei University, College of Dentistry)
±³À°½Ã°£ 10-29 Room 1 11:00~11:20 Role of Hormone Replacement Therapy in Postmenopausal Osteoporosis Management ±è°æ¹Î(Yonsei University)
Åä·Ð 10-29 Room 1 11:20~11:50 Åä·Ð ()
±³À°½Ã°£ 10-29 Room 2 10:20~10:40 Metabolic Surgery Mechanism and Indication David E. CUMMINGS(University of Washington)
±³À°½Ã°£ 10-29 Room 2 10:40~11:00 Metabolic Surgery Selection of Procedure & Clinical Outcomes Wei Jei LEE(Min-Sheng General Hospital)
±³À°½Ã°£ 10-29 Room 2 11:00~11:20 Metabolic Surgery in Korea ÀÌÇõÁØ(Department of Gastrointestinal Surgery, Seoul National University)
Åä·Ð 10-29 Room 2 11:20~11:50 Åä·Ð ()
±³À°½Ã°£ 10-29 Room 3 10:20~10:40 Biological and Clinical Implications of Genomic Alterations in Thyroid Cancers Iñigo LANDA(Havard Medical School)
±³À°½Ã°£ 10-29 Room 3 10:40~11:00 NGS based Therapy for Thyroid Cancer Á¤Çö¾Ö(Division of Hematology-Oncology, Sungkyunkwan University)
±³À°½Ã°£ 10-29 Room 3 11:00~11:20 Targeting Mitochondria in Thyroid Cancer ¹ÚÁ¾ÀÎ(Medical College of Wisconsin)
Åä·Ð 10-29 Room 3 11:20~11:50 Åä·Ð ()
±³À°½Ã°£ 10-29 Room 4 10:20~10:40 Could Midlife Alterations of Hypothalamic Tanycytic Shuttles Lead to Neurodegenerative Disorders Later in Life? Vincent PREVOT(Inserm / University of Lille)
±³À°½Ã°£ 10-29 Room 4 10:40~11:00 The Relationship between Metabolism Changes and Alzheimer ¹¬ÀÎÈñ(Biochemistry & Biomedical Sciences, Seoul National University)
±³À°½Ã°£ 10-29 Room 4 11:00~11:20 Connecting Alzheimer ÀÌÀçÈ«(Neurology, University of Ulsan)
Åä·Ð 10-29 Room 4 11:20~11:50 Åä·Ð ()
ÈÞ½Ä 10-29 11:50~12:00 ÈÞ½Ä ()
±³À°½Ã°£ 10-29 Room 1 12:00~12:20 The Role of DPP-4i in Guidelines and Alogliptin; What are the Differences? ÀüÀçÇÑ(Kyungpook National University)
±³À°½Ã°£ 10-29 Room 1 12:20~12:40 Novel SGLT2 Inhibitor, Enavogliflozin: Drug Profile and its Development History À̽Âȯ(Clinical Pharmacololgy and Therapeutics, Seoul National University)
±³À°½Ã°£ 10-29 Room 2 12:00~12:20 The Latest Options for Treatment of Type 2 Diabetes Patients À±ÁöÈñ(Chonnam National University, Korea)
±³À°½Ã°£ 10-29 Room 2 12:20~12:40 Best Strategy Based on NEW EVIDENCE for Reaching Lower LDL-C Goals À̽Âȯ(The Catholic University of Korea)
½Ä»ç 10-29 12:40~13:10 ½Ä»ç ()
±³À°½Ã°£ 10-29 Room 1 14:00~14:40 Tranional Regulation of Osteoblast Differentiation ·ùÇö¸ð(Seoul National University, School of Dentistry)
±³À°½Ã°£ 10-29 Room 1 14:40~15:10 Namgok lecture Á¶¿µ¹Î(¼¿ïÀÇ´ë)
ÈÞ½Ä 10-29 15:10~15:20 ÈÞ½Ä ()
±³À°½Ã°£ 10-29 Room 1 15:20~15:40 Prevalence, Causes, Consequences of Therapeutic Inertia in Korean Patients with Type 2 DM ±è³²ÈÆ(Korea University)
±³À°½Ã°£ 10-29 Room 1 15:40~16:00 Is Therapeutic Inertia More Of Health System Than Physician? Boon How CHEW(Hospital Pengajar Universiti Putra Malaysia)
±³À°½Ã°£ 10-29 Room 1 16:00~16:20 Clinical Inertia to the Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease ¹éÁ¾ÇÏ(Gyeongsang National University Changwon Hospital)
Åä·Ð 10-29 Room 1 16:20~16:50 Åä·Ð ()
±³À°½Ã°£ 10-29 Room 2 15:20~15:40 Novel Lipid-related Biomarkers in Predicting CVD Adie VILJOEN(East and North Hertfordshire NHS Trust, UK)
±³À°½Ã°£ 10-29 Room 2 15:40~16:00 Role of Incretin in the Regulation of Postprandial Lipoprotein Metabolism Marja-Riitta TASKINEN(University of Helsinki, Finland)
±³À°½Ã°£ 10-29 Room 2 16:00~16:20 Novel Therapeutics for Dyslipidemia ÃÖ¼ºÈñ(Seoul National University, Korea)
Åä·Ð 10-29 Room 2 16:20~16:50 Åä·Ð ()
±³À°½Ã°£ 10-29 Room 3 15:20~15:35 Epigenetic Regulation of Bone FormationBasic Makoto ARAI(Tokyo University)
±³À°½Ã°£ 10-29 Room 3 15:35~15:50 PDK2 Deficiency Prevents Ovariectomy-Induced Bone Loss in Mice by Regulating the RANKL-NFATc1 Pathway During Osteoclastogenesis ±è¹ÎÁö(Kyungpook National University)
±³À°½Ã°£ 10-29 Room 3 15:50~16:05 A Rare Endocrine Disease Highlights New Era of GPCR RegulationTranslational Noriko MAKITA(Tokyo University)
±³À°½Ã°£ 10-29 Room 3 16:05~16:20 Genomic and Tranomic Profiling Reveal Molecular Characteristics of Parathyroid Carcinoma È«³²±â(Yonsei University)
±³À°½Ã°£ 10-29 Room 3 16:20~16:35 Diagnosis and Treatment in Pediatric Bone Diseases: From Childhood to AdulthoodClinical Takuo KUBOTA(Osaka University)
±³À°½Ã°£ 10-29 Room 3 16:35~16:50 Changes in Bone Metabolism after Hematopoietic Stem Cell Transplantation ÇÏÁ¤ÈÆ(The Catholic University of Korea)